Some investors asked questions on the investor interaction platform: Hello, Secretary! Recently, the website of the Ministry of science and technology disclosed that the company was approved for phase III clinical trial of mRNA covid-19 vaccine in December, which was very surprised. In July this year, the company disclosed the initiation of phase III clinical trial of mRNA covid-19 vaccine in China clinical trial registration center. Excuse me, are the three-phase experiments referred to in the two information the same experiment? If not, when will the approved phase III experiment start? Is it related to the phase III experiment started in July?
Walvax Biotechnology Co.Ltd(300142) (300142. SZ) said on the investor interaction platform on December 28 that up to now, the relevant work of the company’s covid-19 mRNA vaccine international multi center phase III clinical trial is being carried out simultaneously in Mexico, Indonesia, the Philippines, Nepal, Guangxi Province and Yunnan Province of China. During the clinical trial, some clinical details will be reported and publicized, but it will not affect the continuous promotion of the clinical trial.
(Daily Economic News)
